NCT00150566View on ClinicalTrials.gov

Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood

PHASE3CompletedINTERVENTIONAL

Enrollment

460

Participants

Timeline

Start Date

February 9, 2004

Primary Completion Date

October 8, 2005

Study Completion Date

October 8, 2005

Conditions

Kidney Failure, Chronic

Interventions

DRUG

Lanthanum carbonate

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Shire

INDUSTRY

NCT00150566 - Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood | Biotech Hunter | Biotech Hunter